These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Prevention strategies for prostate cancer. Schmitz-Dräger BJ; Lümmen G; Bismarck E; Fischer C Minerva Urol Nefrol; 2012 Dec; 64(4):225-31. PubMed ID: 23288209 [TBL] [Abstract][Full Text] [Related]
7. Co-clinical Analysis of a Genetically Engineered Mouse Model and Human Prostate Cancer Reveals Significance of NKX3.1 Expression for Response to 5α-reductase Inhibition. Dutta A; Panja S; Virk RK; Kim JY; Zott R; Cremers S; Golombos DM; Liu D; Mosquera JM; Mostaghel EA; Barbieri CE; Mitrofanova A; Abate-Shen C Eur Urol; 2017 Oct; 72(4):499-506. PubMed ID: 28385453 [TBL] [Abstract][Full Text] [Related]
8. Nutrition, physical activity, and lifestyle factors in prostate cancer prevention. Ballon-Landa E; Parsons JK Curr Opin Urol; 2018 Jan; 28(1):55-61. PubMed ID: 29049045 [TBL] [Abstract][Full Text] [Related]
9. Impact of 5α-reductase inhibitors on men followed by active surveillance for prostate cancer. Finelli A; Trottier G; Lawrentschuk N; Sowerby R; Zlotta AR; Radomski L; Timilshina N; Evans A; van der Kwast TH; Toi A; Jewett MA; Trachtenberg J; Fleshner NE Eur Urol; 2011 Apr; 59(4):509-14. PubMed ID: 21211899 [TBL] [Abstract][Full Text] [Related]
10. [Pharmaco and diet based prostate cancer prevention]. Eisinger F; Cancel-Tassin G; Azzouzi AR; Gravis G; Rossi D; Cussenot O Bull Cancer; 2013 May; 100(5):497-507. PubMed ID: 23694994 [TBL] [Abstract][Full Text] [Related]
11. Chemoprevention of prostate cancer. Vemana G; Hamilton RJ; Andriole GL; Freedland SJ Annu Rev Med; 2014; 65():111-23. PubMed ID: 24188663 [TBL] [Abstract][Full Text] [Related]
18. [Opportunities and risks of 5α reductase inhibitors in the medical management of Active surveillance for localized prostate cancer]. Linares Espinos E; Carballido Rodriguez J Arch Esp Urol; 2014 Jun; 67(5):457-61. PubMed ID: 24914845 [TBL] [Abstract][Full Text] [Related]
19. Overview of pivotal studies for prostate cancer risk reduction, past and present. Andriole GL Urology; 2009 May; 73(5 Suppl):S36-43. PubMed ID: 19375625 [TBL] [Abstract][Full Text] [Related]